Cencora, Inc. COR
306.92
(2.95)
(0.95%)
as of 25 Sep
- Market cap
- $59.1B
- P/E
- 22.7×
Follow COR
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cencora, Inc. (COR) Total debt
Cencora, Inc.'s total debt at the end of fiscal 2025 was $7.7B, up 74.6% from $4.4B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $11.7B. Over the past ten years it has ranged from $3.7B (fiscal 2015) to $7.7B (fiscal 2025) — the current reading is the highest in ten years. Cencora, Inc. ranks 2nd of 11 Medical Distribution companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $7.7B | 74.58% |
| FY2024 | $4.4B | (8.34%) |
| FY2023 | $4.8B | (16.05%) |
| FY2022 | $5.7B | (14.68%) |
| FY2021 | $6.7B | 62.25% |
| FY2020 | $4.1B | (8.32%) |
| FY2019 | $4.5B | (3.63%) |
| FY2018 | $4.7B | 22.90% |
| FY2017 | $3.8B | (14.99%) |
| FY2016 | $4.5B | 19.35% |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $11.7B | (5.35%) |
| Mar 2026 | $12.4B | 56.35% |
| Dec 2025 | $7.9B | 3.41% |
| Sep 2025 | $7.7B | (7.03%) |
| 42 more quarters | Free account |
Against its own ten years
Low $3.7B
High $7.7B
Ten-year median
$4.5B
Current reading's percentile
100
Total debt against peers
| Company | Total debt |
|---|---|
| MCK McKesson Corporation compare | $14.8B |
| COR Cencora, Inc. | $11.7B |
| CAH Cardinal Health, Inc. compare | $8.9B |
| HSIC Henry Schein, Inc. compare | $2.4B |
| ACH Accendra Health, Inc. compare | $1.7B |
| FOCL FocalTherics compare | $40.1M |
| YI 111, Inc. Sponsored ADR compare | $37.3M |
| COSM Cosmos Health Inc. compare | $11.8M |
| AHG Akso Health Group Sponsored ADR compare | $4.6M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on COR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement